On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayNov 15, 2021 11:03 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Q2 Financial Results, Business Highlights

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has released its unaudited second-quarter results and announced a conference call to review the report. The report covers the period ended Sept. 30, 2021. Highlights in the report included the company’s announcement of preclinical data for its novel deuterated psilocybin analog, CYB003, for the potential treatment of major depressive disorder and alcohol use disorder. The company has also been granted a Schedule I manufacturing license from the U.S. Drug Enforcement Agency for its Boston-area research lab and has received FDA approval to proceed with a company-sponsored…

Continue Reading

MondayNov 15, 2021 10:06 am

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation at Q4 Virtual Investor Summit

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”), will be presenting at the upcoming Q4 Virtual Investor Summit. The summit is scheduled for Nov. 17, 2021. Vivos CEO Kirk Huntsman, chief financial officer Brad Amman, and investor relations officer Ed Loew will provide key information about the company during a life webcast slated to begin at 11:45 a.m. EST. To view the full presentation, visit https://nnw.fm/8j4FO To view the full press release, visit https://nnw.fm/ItHul About Vivos Therapeutics Inc. Vivos Therapeutics is a medical technology company focused…

Continue Reading

FridayNov 12, 2021 3:09 pm

NetworkNewsBreaks – Mind Cure Health Inc.’s (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) iSTRYM Opening New Revenue Source, Helping Fuel Further Growth, Expansion

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, recently signed a non-binding letter of intent (“LOI”) with Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF), a biotech company with clinical operations researching, developing and delivering psychedelic medicine to treat addiction. “Under the LOI, MINDCURE becomes a distributor of Awakn’s ketamine-assisted psychotherapy for alcohol use disorder in the United States and Canada, through its proprietary digital therapeutics platform, iSTRYM,” reads a recent article. In addition to distributing its partners’ protocols, MINDCURE will also be distributing its own protocols through iSTRYM.…

Continue Reading

FridayNov 12, 2021 12:08 pm

NetworkNewsBreaks – IBN Continues Collaboration with Investor Summit Group for Q4 Virtual Summit

IBN (“InvestorBrandNetwork”), a multifaceted communications organization engaged in connecting companies to the investment community through 50+ brands, today announced that it will return as official media sponsor for the Investor Summit Group’s Q4 Virtual Summit. The event is set to be held in an entirely digital format on Nov. 16-17, 2021. Known for hosting some of North America’s largest independent investor conferences, the Investor Summit Group routinely brings together some of the continent’s most exciting and influential micro and small-cap companies. The Q4 Virtual Summit will feature close to 100 companies and provide attendees an invaluable opportunity to connect and hear from some…

Continue Reading

FridayNov 12, 2021 11:33 am

NetworkNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Eyeing Q1 2022 Delivery of Highest-Quality Retail Products from Florida Grow Operations

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently completed phase one of an aggressive three-phase development strategy for its Florida facilities, located in Apopka and Sanderson. Phase one entailed the rapid development of the Apopka facility. RWB also announced that it had commenced operation in late September after receiving regulatory approval to begin cultivation. “The initial licensed area in Apopka is capable of producing 85g of flower per plant, translating to projected annual revenue in excess of $10 million. The Apopka facility will supply RWB’s phase two of the strategy, which entails activating thirty 16’ by 40’ customized,…

Continue Reading

FridayNov 12, 2021 11:20 am

NetworkNewsBreaks – Excellon Resources Inc. (NYSE American: EXN) (TSX: EXN) (FSE: E4X2) Reigniting Saxony’s Storied Mining History

Excellon Resources (NYSE American: EXN) (TSX: EXN) (FSE: E4X2) is actively working to reignite the Saxony region’s proud and storied history, which has long been synonymous with silver mining. According to Ben Pullinger, SVP Geology and Corporate Development for Excellon, Saxony has become an important jurisdiction for the company over that past year. “In mid-2020, Excellon announced that it had entered into a research and development alliance with the Helmholtz Institute Freiberg (‘HIF’). The company’s team seeks to apply modern exploration technology on the historically significant Silver City mineral field in Saxony, Germany,” reads a recent article. Excellon, which holds…

Continue Reading

FridayNov 12, 2021 11:00 am

NetworkNewsBreaks – MoneyShow’s Upcoming Event to Shine the Spotlight on Key Portfolio Diversification Strategies

MoneyShow, a leading producer of financial conferences for affluent investors, active traders and financial advisors, will be hosting the upcoming Accredited Investors Virtual Expo. The event is slated to take place in an entirely digital format on Nov. 16-18, 2021, and provide investors and attendees new methods to build their portfolios for improved yields, appreciation and diversification. This year’s expo will provide real-time access to the financial industry’s brightest minds and feature a strong lineup of more than 35 leading market analysts, money managers and investment gurus to share analysis, advice and strategies designed to identify and capitalize on opportunities…

Continue Reading

FridayNov 12, 2021 10:43 am

NetworkNewsBreaks – Laredo Oil Inc. (LRDC) Eyes Expansion Potential for Lustre Oil Field Properties

Laredo Oil (OTC: LRDC) today announced its receipt of a reserve report from an independent petroleum engineering firm. The report estimates that interests of proved undeveloped, probable undeveloped and contingent reserves, and forecasts of economics attributable to certain properties in the Western Williston Basin of Montana for oil interests acquired by Lustre Oil Company LLC, a wholly owned Laredo Oil subsidiary, total $41 million of cumulative cash flow discounted at 10%. According to the update, the evaluation, effective Nov. 1, 2021, was prepared using constant prices and costs and conforms to Item 1202(a)(8) of Regulation S-K and other rules of…

Continue Reading

ThursdayNov 11, 2021 3:40 pm

NetworkNewsBreaks – DHI Group, Inc. (NYSE: DHX) Featured in Research Note from Sidoti

Price Target Raised; Estimates Raised DHI Group, Inc. (NYSE: DHX) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Raise Target To $8 (From $7), Increase Revenue Projections Through 2023; DHX’s 3Q:21 Results, 4Q:21 Guidance Reflect Robust Bookings Growth And Improving Underlying Business Trends.” Click here to access the full report. About DHI Group, Inc. DHI Group is a provider of AI-powered career marketplaces that focus on technology roles. DHI’s two brands, Dice and ClearanceJobs, enable recruiters and hiring managers to efficiently search for and connect with highly skilled technologists based…

Continue Reading

ThursdayNov 11, 2021 3:29 pm

NetworkNewsBreaks – Myomo, Inc. (NYSE American: MYO) Featured in Research Note from Sidoti

Earnings Release Myomo, Inc. (NYSE American: MYO) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Myomo’s 3Q:21 Results Exceed Our Estimates; Estimate Expanded Reimbursement Will Fuel 30%-40% Annual Sales Growth In 2022 And 2023; Introduce 2023 Forecast; Maintain BUY, $23 Target.” Click here to access the full report. About Myomo, Inc. Myomo is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217